Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · IEX Real-Time Price · USD
2.580
+0.005 (0.19%)
At close: Jul 19, 2024, 4:00 PM
2.650
+0.070 (2.71%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Checkpoint Therapeutics Market Cap
Checkpoint Therapeutics has a market cap or net worth of $96.44 million as of July 22, 2024. Its market cap has increased by 147.29% in one year.
Market Cap
96.44M
Enterprise Value
85.20M
1-Year Change
147.29%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since June 26, 2017, Checkpoint Therapeutics's market cap has decreased from $252.20M to $96.44M, a decrease of -61.76%. That is a compound annual growth rate of -12.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 95.10M | 76.44% |
Dec 29, 2023 | 53.90M | 13.47% |
Dec 30, 2022 | 47.50M | -81.77% |
Dec 31, 2021 | 260.50M | 44.80% |
Dec 31, 2020 | 179.90M | 173.82% |
Dec 31, 2019 | 65.70M | 5.97% |
Dec 31, 2018 | 62.00M | -37.37% |
Dec 29, 2017 | 99.00M | -60.75% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
VistaGen Therapeutics | 98.91M |
Omega Therapeutics | 98.73M |
Sagimet Biosciences | 98.61M |
Sensus Healthcare | 98.36M |
Xtant Medical Holdings | 96.53M |
Anixa Biosciences | 94.10M |
Aclaris Therapeutics | 94.07M |
111, Inc. | 93.71M |